Advanced fructo-oligosaccharides improve itching and aberrant epidermal lipid composition in children with atopic dermatitis

Sukyung Kim, Bae Gon Kang, Soonok Sa, Se Young Park, Kyungheon Ryu, Jinyoung Lee, Boram Park, Mijeong Kwon, Yeonghee Kim, Jiwon Kim, Sanghee Shin, Sehun Jang, Byung Eui Kim, Jaewoong Bae, Kangmo Ahn, Kwang Hyeon Liu, Jihyun Kim

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction: The effects of fructo-oligosaccharides (FOS) on atopic dermatitis (AD) have not been determined. Methods: In a randomized, double-blind, placebo-controlled trial, children with AD aged 24 months to 17 years received either advanced FOS containing 4.25 g of 1-kestose or a placebo (maltose) for 12 weeks. Results: The SCORAD and itching scores were reduced in patients treated with both FOS (all p < 0.01) and maltose (p < 0.05 and p < 0.01). Sleep disturbance was improved only in the FOS group (p < 0.01). The FOS group revealed a decreased proportion of linoleic acid (18:2) esterified omega-hydroxy-ceramides (EOS-CERs) with amide-linked shorter chain fatty acids (C28 and C30, all p < 0.05), along with an increased proportion of EOS-CERs with longer chain fatty acids (C32, p < 0.01). Discussion: FOS may be beneficial in alleviating itching and sleep disturbance, as well as improving skin barrier function in children with AD.

Original languageEnglish
Article number1383779
JournalFrontiers in Microbiology
Volume15
DOIs
StatePublished - 2024

Keywords

  • atopic dermatitis
  • fatty acid elongase
  • fructo-oligosaccharides
  • kestose
  • prebiotics

Fingerprint

Dive into the research topics of 'Advanced fructo-oligosaccharides improve itching and aberrant epidermal lipid composition in children with atopic dermatitis'. Together they form a unique fingerprint.

Cite this